Regulus Therapeutics (RGLS) Misses Q1 EPS by 3c, Announces Workforce Reduction; CEO to Resign
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Go back to Regulus Therapeutics (RGLS) Misses Q1 EPS by 3c, Announces Workforce Reduction; CEO to Resign
May 4, 2017 4:23 PM EDT
Regulus Therapeutics (NASDAQ: RGLS) Halted, News Pending
...
More